BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1362 related articles for article (PubMed ID: 27058326)

  • 21. Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.
    Oteo J; Ortega A; Bartolomé R; Bou G; Conejo C; Fernández-Martínez M; González-López JJ; Martínez-García L; Martínez-Martínez L; Merino M; Miró E; Mora M; Navarro F; Oliver A; Pascual Á; Rodríguez-Baño J; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Pérez-Vázquez M; Campos J;
    Antimicrob Agents Chemother; 2015; 59(6):3406-12. PubMed ID: 25824224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The First Enterobacter cloacae Co-Producing NDM and OXA-48 Carbapenemases and Interhospital Spread of OXA-48 and NDM-Producing Klebsiella pneumoniae in Turkey.
    Haciseyitoglu D; Dokutan A; Abulaila A; Erdem F; Cag Y; Ozer S; Aktas Z
    Clin Lab; 2017 Jul; 63(7):1213-1222. PubMed ID: 28792697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant
    Shortridge D; Kantro V; Castanheira M
    Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.
    Iraz M; Özad Düzgün A; Sandallı C; Doymaz MZ; Akkoyunlu Y; Saral A; Peleg AY; Özgümüş OB; Beriş FŞ; Karaoğlu H; Çopur Çiçek A
    Ann Lab Med; 2015 Nov; 35(6):595-601. PubMed ID: 26354347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center.
    Gupta V; Bansal N; Singla N; Chander J
    J Microbiol Immunol Infect; 2013 Apr; 46(2):104-8. PubMed ID: 22541536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular study of carbapenemase genes in clinical isolates of Enterobacteriaceae resistant to carbapenems and determining their clonal relationship using pulsed-field gel electrophoresis.
    Shahcheraghi F; Aslani MM; Mahmoudi H; Karimitabar Z; Solgi H; Bahador A; Alikhani MY
    J Med Microbiol; 2017 May; 66(5):570-576. PubMed ID: 28485708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
    Rimrang B; Chanawong A; Lulitanond A; Wilailuckana C; Charoensri N; Sribenjalux P; Phumsrikaew W; Wonglakorn L; Kerdsin A; Chetchotisakd P
    J Antimicrob Chemother; 2012 Nov; 67(11):2626-30. PubMed ID: 22796889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal Dissemination of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae in Neonates.
    Yin D; Dong D; Li K; Zhang L; Liang J; Yang Y; Wu N; Bao Y; Wang C; Hu F
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of a New Variant OXA-204 and OXA-48 Carbapenemases Plasmids Encoded in Klebsiella pneumoniae Clinical Isolates in Tunisia.
    Ouertani R; Ben Jomàa-Jemili M; Gharsa H; Limelette A; Guillard T; Brasme L; de Champs C; Chouchani C
    Microb Drug Resist; 2018 Mar; 24(2):142-149. PubMed ID: 28737463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boronic acid disk diffusion for the phenotypic detection of polymerase chain reaction-confirmed, carbapenem-resistant, gram-negative bacilli isolates.
    Elsherif R; Ismail D; Elawady S; Jastaniah S; Al-Masaudi S; Harakeh S; Karrouf G
    BMC Microbiol; 2016 Jul; 16(1):135. PubMed ID: 27368987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.
    Mushtaq S; Woodford N; Hope R; Adkin R; Livermore DM
    J Antimicrob Chemother; 2013 Jul; 68(7):1601-8. PubMed ID: 23449829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiological efficiency of the combinations of two carbapenems against antibiotic resistant Klebsiella pneumoniae strains.
    Tapalski DV; Timoshkova EV; Petrovskaya TA; Osipkina OV; Karpov IA
    Klin Lab Diagn; 2021 May; 66(5):304-309. PubMed ID: 34047517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of ertapenem-EMB Agar with traditional methods for screening carbapenem-resistant Klebsiella pneumoniae from rectal swabs].
    Perçin D; Colakoğlu S; Durmaz S; Ekincioğlu P
    Mikrobiyol Bul; 2012 Oct; 46(4):546-52. PubMed ID: 23188568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
    Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
    Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong.
    Ho PL; Cheung YY; Wang Y; Lo WU; Lai EL; Chow KH; Cheng VC
    Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):379-85. PubMed ID: 26740321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbapenem resistance in
    Jaggi N; Chatterjee N; Singh V; Giri SK; Dwivedi P; Panwar R; Sharma AP
    Acta Microbiol Immunol Hung; 2019 Sep; 66(3):367-376. PubMed ID: 31438725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
    Robert J; Pantel A; Merens A; Meiller E; Lavigne JP; Nicolas-Chanoine MH;
    BMC Infect Dis; 2017 Jan; 17(1):78. PubMed ID: 28095794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
    Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
    Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of VIM, NDM and OXA-48 producing carbapenem resistant Enterobacterales among clinical isolates in Southern Hungary.
    Gajdács M; Ábrók M; Lázár A; Jánvári L; Tóth Á; Terhes G; Burián K
    Acta Microbiol Immunol Hung; 2020 Dec; 67(4):209-215. PubMed ID: 33258795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
    Alsharapy SA; Gharout-Sait A; Muggeo A; Guillard T; Cholley P; Brasme L; Bertrand X; Moghram GS; Touati A; De Champs C
    Microb Drug Resist; 2020 Mar; 26(3):211-217. PubMed ID: 31397629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.